Search
01/12/2025
Framework and accreditation criteria of Web Médica Acreditada: Consolidating 25 years of development
Wisen, GT, Casasa, A, Perez, MM, Selma, JPI. Framework and accreditation criteria of Web Médica Acreditada: Consolidating 25 years of development. MEDICINA CLINICA. 2025; 165(6)DOI:10.1016/j.medcli.2025.107141. PMID:. IF:2.100(Q2/3D).
01/12/2025
Electroencephalographic manifestations of intracranial hypertension in a patient with ventriculoperitoneal shunt malfunction
Bernardi, E, Ros-Castello, V, Coronel-Coronel, M, Lazzari, R, Aibar-Durán, JA, Sierra-Marcos, A. Electroencephalographic manifestations of intracranial hypertension in a patient with ventriculoperitoneal shunt malfunction. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY. 2025; 133DOI:10.1016/j.seizure.2025.10.017. PMID:41175508. IF:2.800(Q2/5D).
01/12/2025
Lipomatous metaplasia in cardiac CT: when 'normal' extracellular volume does not indicate myocardial viability - a case report
Pieszko, K, González, CR, Petracca, RL, Medel, DV. Lipomatous metaplasia in cardiac CT: when 'normal' extracellular volume does not indicate myocardial viability - a case report. European Heart Journal-Case Reports. 2025; 9(12)DOI:10.1093/ehjcr/ytaf612. PMID:41384087. IF:(Q/D).
01/12/2025
Guideline-directed medical therapy after revascularization and outcomes in ischaemic cardiomyopathy
Moliner-Abos, C, Calvo-Barcelo, M, Solé-Gonzalez, E, Martín, AB, Brugués, PF, Vega, JS, Jubany, JV, Vallverdú, MF, Ferrer, MT, Castillo, PET, Mancera, JCD, Rigau, PV, Olives, RV, Lopez, CD, Bayés-Genís, A, Aizpurua, DA, González, IF, Pérez, SM. Guideline-directed medical therapy after revascularization and outcomes in ischaemic cardiomyopathy. ESC Heart Failure. 2025; 12(6)DOI:10.1002/ehf2.70014. PMID:41243815. IF:3.700(Q1/3D).
01/12/2025
Amphilimus-eluting versus zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: extended follow-up of the SUGAR randomised controlled trial
Salinas, P, Romaguera, R, Gómez-Lara, J, Brugaletta, S, Gómez-Menchero, A, Martín, P, Romero, M, García-Blas, S, Jiménez, M, Jiménez, VA, Bordes, P, Bayón, J, Salvatella, N, Alameda, M, Hyun-Lee, D, Trillo-Nouche, R, López-Benito, M, Frutos, A, Moreu, J, del Blanco, BG, Mohandes, M, Ojeda, FB, Hernández, FH, Pinar-Bermúdez, E, Jiménez-Quevedo, P, Rosselló, X, Pocock, S, Sabaté, M, Gómez-Hospital, JA, Comin-Colet, J, Gonzalo, N, Ortiz, AF, SUGAR Trial Investigators. Amphilimus-eluting versus zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: extended follow-up of the SUGAR randomised controlled trial. HEART. 2025; 111(24)DOI:10.1136/heartjnl-2025-325773. PMID:40562528. IF:4.400(Q1/3D).
01/12/2025
Transforming atrial fibrillation management by targeting comorbidities and reducing atrial fibrillation burden: the 10th AFNET/EHRA consensus conference
Svennberg, E, Merino, JL, Andrade, J, Anselmino, M, Arbelo, E, Boersma, E, Boriani, G, Breithardt, G, Chung, MN, Chyou, J, Cohen, A, Nielsen, JC, Dichtl, W, Diederichsen, SZ, Dobrev, D, Doehner, W, Dworatzek, E, Fabritz, L, Filgueiras-Rama, D, Gimpelewicz, C, Hack, G, Hatem, S, Healey, J, Heidbuchel, H, Hijazi, Z, Holst, AG, Hove-Madsen, L, Jalife, J, van Leerdam, R, Linz, D, Lip, GYH, Lubitz, S, de Melis, M, Meyer, R, Orczykowski, M, Parwani, AS, Porta-Sanchez, A, de Potter, T, Ravens, U, Rienstra, M, Rillig, A, Rivard, L, Scherr, D, Schnabel, RB, Schotten, U, Simovic, S, Sinner, M, Sohns, C, Sommer, P, Steinbeck, G, Steven, D, Sultan, A, Thomalla, G, Toennis, T, Tzeis, S, Voigt, N, Wadhwa, M, Wakili, R, Witt, H, Goette, A, Kirchhof, P. Transforming atrial fibrillation management by targeting comorbidities and reducing atrial fibrillation burden: the 10th AFNET/EHRA consensus conference. EUROPACE. 2025; 27(12)DOI:10.1093/europace/euaf318. PMID:41392710. IF:7.400(Q1/2D).